Literature DB >> 9770156

Mycobacterium malmoense infections in the United States, January 1993 through June 1995.

U T Buchholz1, M M McNeil, L E Keyes, R C Good.   

Abstract

Mycobacterium malmoense is a nontuberculous mycobacterium rarely encountered in the United States. However, isolations of M. malmoense from 73 patients (11 in 1992, 35 in 1993, and 27 in 1994) were reported to the Centers for Disease Control and Prevention. We contacted state mycobacteriology laboratories and health care providers of patients whose M. malmoense isolations were reported from January 1993 through June 1995. To assign disease status for these patients, we used the criteria of the American Thoracic Society. Of 60 evaluable patients with disease status, only six (10%) had disease due to M. malmoense (five adults with pulmonary disease and one child with cervical lymphadenitis). We conclude that the number of patients with disease due to M. malmoense remains low. Increased isolation of this species may be due to the increased use of more sensitive and specific laboratory methods. For surveillance purposes, multiple M. malmoense isolates and age of younger than 10 years appear to be the best predictors for M. malmoense disease.

Entities:  

Mesh:

Year:  1998        PMID: 9770156     DOI: 10.1086/514702

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Pulmonary Infection Due to Mycobacterium malmoense in a Patient with Crohn Disease.

Authors:  Cory D Cowan; John J Hawboldt; Mazen Bader
Journal:  Can J Hosp Pharm       Date:  2009-11

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 3.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

4.  Cervical abscess in an immunocompetent patient with Mycobacterium malmoense pulmonary disease.

Authors:  Joao N Duarte; Nuno Marques; Leonor Barroso; Isabel Ramos; Rosa Sá; David Sanz; Artur Ferreira; Saraiva da Cunha
Journal:  Oral Maxillofac Surg       Date:  2011-11-05

Review 5.  Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species.

Authors:  W R Butler; L S Guthertz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Mycobacterium malmoense lymphadenitis in Spain: first two cases in immunocompetent patients.

Authors:  A I López-Calleja; M A Lezcano; S Samper; F de Juan; M J Revillo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-26       Impact factor: 3.267

7.  Pulmonary Cavity From Mycobacterium malmoense in an HIV-Infected Patient: Complicated by Bronchopleural Fistula.

Authors:  Eric Abston; Harrison Farber
Journal:  Open Forum Infect Dis       Date:  2018-01-24       Impact factor: 3.835

Review 8.  An association between Mycobacterium malmoense and coal workers' pneumoconiosis.

Authors:  Emmet E McGrath; Philip Bardsley
Journal:  Lung       Date:  2008-08-30       Impact factor: 2.584

9.  Submandibular lymphadenitis due to Mycobacterium malmoense: first reported case from Greece.

Authors:  Elpis Mantadakis; Chrysostomos Soultanidis; Athanasia Christidou; Sofia Maraki
Journal:  BMJ Case Rep       Date:  2020-04-26

10.  Lung Disease Caused by Mycobacterium malmoense in an Immunocompetent Patient.

Authors:  Min Kyung Jeon; Jung A Yoon; Junhwan Kim; Sangyoung Yi; Heungsup Sung; Tae Sun Shim; Kyung-Wook Jo
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.